COMMUNIQUÉS West-GlobeNewswire

NovuHealth Research Confirms that Engagement Drives Healthy Activities among Low-Income Consumers
01/08/2018
Data from a Medicaid Program in New York City Reveal that Targeted Plan Members Were 92% More Likely to Complete Healthy Activities MINNEAPOLIS, Aug. 01, 2018 (GLOBE NEWSWIRE) -- NovuHealth , the healthcare industry’s [...]
New study on advancing patient-reported outcome measures to increase patient-centered care
01/08/2018
Study appears in August 2018 issue of The Joint Commission Journal on Quality and Patient Safety OAKBROOK TERRACE, Ill., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Interest is growing in using patients’ own reports of their [...]
Lysogene Announces Upcoming Presentations at the 2018 International MPS symposium
01/08/2018
CAMBRIDGE, Mass. and PARIS, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Lysogene (FR0013233475 – LYS), a pioneering biopharmaceutical company specializing in gene therapy targeting central nervous system (CNS) diseases, today [...]
Tabula Rasa HealthCare Expands Medication Risk Mitigation Offerings to Western Europe
01/08/2018
MOORESTOWN, N.J., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced it has entered into a [...]
NICOX : Number of voting rights as of July 31, 2018
01/08/2018
Nicox SA Société anonyme with a registered capital of € 29,588,510 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On August 1, 2018, MONTHLY PUBLICATION OF THE [...]
NICOX : Nombre de droits de vote au 31 juillet 2018
01/08/2018
Nicox SA Société anonyme au capital de 29 588 510 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 1 août 2018, PUBLICATION MENSUELLE DU NOMBRE D'ACTIONS [...]
Lysogene Reports Second Quarter Cash Position and Provides Business and Strategic Update
01/08/2018
CAMBRIDGE, Mass. and PARIS, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Lysogene (FR0013233475 – LYS), a pioneering biopharmaceutical company specializing in gene therapy targeting central nervous system (CNS) diseases, today [...]
BioSig Technologies Files Application to Uplist to the NASDAQ
01/08/2018
Listing to Support Institutional Outreach Ahead of Commercialization Santa Monica, CA, Aug. 01, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. ( BSGM ), a medical device company developing a proprietary biomedical [...]
Pernix Therapeutics Announces a Series of Transactions to Strengthen Its Balance Sheet and Improve Financial Flexibility
01/08/2018
MORRISTOWN, N.J., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announces a series of transactions aimed at strengthening its balance sheet and [...]
CORRECTING and REPLACING -- Neuralstem, Inc.
01/08/2018
GERMANTOWN, Md., Aug. 01, 2018 (GLOBE NEWSWIRE) -- In a release issued yesterday by Neuralstem, Inc. (Nasdaq:CUR), please note the headline should be, "Neuralstem Announces Initiation of Phase 2 Clinical Trial of NSI- [...]
Medtronic Announces Paurvi Bhatt as President of Medtronic Foundation
01/08/2018
DUBLIN - August 1, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced Paurvi Bhatt as the new President of the Medtronic Foundation and Vice President of Medtronic Philanthropy. [...]
Adamas Pharmaceuticals Launches “Dyskinesia Is A Jerk™,” a Campaign to Raise Awareness and Highlight the Impact of Parkinson’s Disease Dyskinesia
01/08/2018
- Despite significant impact on daily life and the ability to treat primary symptoms of Parkinson’s disease dyskinesia (uncontrolled jerking or twisting movements), symptoms are often not recognized or discussed by [...]
Distribution Agreement with Micro-Tech Endoscopy USA Represents Significant Milestone for Medigus to Enter U.S. Market
01/08/2018
OMER, Israel, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and an innovator in direct visualization technology, [...]
Rubicon: Greenhouse Grown Organic Cannabis is Not Easy, But Worth the Effort -- CFN Media
01/08/2018
SEATTLE, WA , Aug. 01, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article [...]
Acer Therapeutics Announces Pricing of Underwritten Public Offering
01/08/2018
NEWTON, Mass., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare [...]
Zynerba Pharmaceuticals to Present at the 38th Annual Canaccord Genuity Growth Conference
01/08/2018
DEVON, Pa., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]
Tauriga Sciences Inc. Reports Quarterly Net Profit of $166,788 for its 1st Fiscal Quarter of 2019
01/08/2018
NEW YORK, NY, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB: TAUG) (OTCQB: TAUGD) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of [...]
CV Sciences, Inc. Reports Second Quarter 2018 Financial Results
01/08/2018
Growth and Profitability Driven by Key Financial Performance Metrics, including Record GAAP Net Income of $3.2 Million Management to Host Second Quarter 2018 Financial Results Conference Call on August 1, 2018 at 4:15pm [...]
Bellerophon Provides Business Update and Reports Second Quarter 2018 Financial Results
01/08/2018
WARREN, N.J., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today provided a business update and reported [...]

Pages